Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Sherri M. Biendarra-Tiegs, Frank J. Secreto, Timothy J. Nelson

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Induced pluripotent stem cells (iPSCs) offer great promise in the areas of disease modeling, basic research, drug development, and regenerative medicine. Much of their value comes from the fact that they can be used to create otherwise inaccessible cell types, such as cardiomyocytes, which are genetically matched to a patient or any other individual of interest. A consistent issue plaguing the iPSC platform, however, involves excessive variability exhibited in the differentiated products. This includes discrepancies in genetic, epigenetic, and transcriptional features, cell signalling, the cell types produced from cardiac differentiation, and cardiomyocyte functionality. These properties can result from both the somatic source cells and environmental conditions related to the derivation and handling of these cells. Understanding the potential sources of variability, along with determining which factors are most relevant to a given application, are essential in advancing iPSC-based technologies.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer
Pages1-29
Number of pages29
DOIs
StatePublished - Jan 1 2020

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1212
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Induced Pluripotent Stem Cells
Stem cells
Cardiac Myocytes
Cell signaling
Regenerative Medicine
Epigenomics
Pharmaceutical Preparations
Technology
Research

Keywords

  • Cardiomyocytes
  • Cellular microenvironment
  • Differentiation
  • Induced pluripotent stem cells
  • Phenotypic variability
  • Stem cell heterogeneity

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Biendarra-Tiegs, S. M., Secreto, F. J., & Nelson, T. J. (2020). Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes. In Advances in Experimental Medicine and Biology (pp. 1-29). (Advances in Experimental Medicine and Biology; Vol. 1212). Springer. https://doi.org/10.1007/5584_2019_350

Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes. / Biendarra-Tiegs, Sherri M.; Secreto, Frank J.; Nelson, Timothy J.

Advances in Experimental Medicine and Biology. Springer, 2020. p. 1-29 (Advances in Experimental Medicine and Biology; Vol. 1212).

Research output: Chapter in Book/Report/Conference proceedingChapter

Biendarra-Tiegs, SM, Secreto, FJ & Nelson, TJ 2020, Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 1212, Springer, pp. 1-29. https://doi.org/10.1007/5584_2019_350
Biendarra-Tiegs SM, Secreto FJ, Nelson TJ. Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes. In Advances in Experimental Medicine and Biology. Springer. 2020. p. 1-29. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/5584_2019_350
Biendarra-Tiegs, Sherri M. ; Secreto, Frank J. ; Nelson, Timothy J. / Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Advances in Experimental Medicine and Biology. Springer, 2020. pp. 1-29 (Advances in Experimental Medicine and Biology).
@inbook{8c4a201fa7d24c1f9d7ef433dd8f4fd3,
title = "Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes",
abstract = "Induced pluripotent stem cells (iPSCs) offer great promise in the areas of disease modeling, basic research, drug development, and regenerative medicine. Much of their value comes from the fact that they can be used to create otherwise inaccessible cell types, such as cardiomyocytes, which are genetically matched to a patient or any other individual of interest. A consistent issue plaguing the iPSC platform, however, involves excessive variability exhibited in the differentiated products. This includes discrepancies in genetic, epigenetic, and transcriptional features, cell signalling, the cell types produced from cardiac differentiation, and cardiomyocyte functionality. These properties can result from both the somatic source cells and environmental conditions related to the derivation and handling of these cells. Understanding the potential sources of variability, along with determining which factors are most relevant to a given application, are essential in advancing iPSC-based technologies.",
keywords = "Cardiomyocytes, Cellular microenvironment, Differentiation, Induced pluripotent stem cells, Phenotypic variability, Stem cell heterogeneity",
author = "Biendarra-Tiegs, {Sherri M.} and Secreto, {Frank J.} and Nelson, {Timothy J.}",
year = "2020",
month = "1",
day = "1",
doi = "10.1007/5584_2019_350",
language = "English (US)",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer",
pages = "1--29",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes

AU - Biendarra-Tiegs, Sherri M.

AU - Secreto, Frank J.

AU - Nelson, Timothy J.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Induced pluripotent stem cells (iPSCs) offer great promise in the areas of disease modeling, basic research, drug development, and regenerative medicine. Much of their value comes from the fact that they can be used to create otherwise inaccessible cell types, such as cardiomyocytes, which are genetically matched to a patient or any other individual of interest. A consistent issue plaguing the iPSC platform, however, involves excessive variability exhibited in the differentiated products. This includes discrepancies in genetic, epigenetic, and transcriptional features, cell signalling, the cell types produced from cardiac differentiation, and cardiomyocyte functionality. These properties can result from both the somatic source cells and environmental conditions related to the derivation and handling of these cells. Understanding the potential sources of variability, along with determining which factors are most relevant to a given application, are essential in advancing iPSC-based technologies.

AB - Induced pluripotent stem cells (iPSCs) offer great promise in the areas of disease modeling, basic research, drug development, and regenerative medicine. Much of their value comes from the fact that they can be used to create otherwise inaccessible cell types, such as cardiomyocytes, which are genetically matched to a patient or any other individual of interest. A consistent issue plaguing the iPSC platform, however, involves excessive variability exhibited in the differentiated products. This includes discrepancies in genetic, epigenetic, and transcriptional features, cell signalling, the cell types produced from cardiac differentiation, and cardiomyocyte functionality. These properties can result from both the somatic source cells and environmental conditions related to the derivation and handling of these cells. Understanding the potential sources of variability, along with determining which factors are most relevant to a given application, are essential in advancing iPSC-based technologies.

KW - Cardiomyocytes

KW - Cellular microenvironment

KW - Differentiation

KW - Induced pluripotent stem cells

KW - Phenotypic variability

KW - Stem cell heterogeneity

UR - http://www.scopus.com/inward/record.url?scp=85077734925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077734925&partnerID=8YFLogxK

U2 - 10.1007/5584_2019_350

DO - 10.1007/5584_2019_350

M3 - Chapter

C2 - 30850960

AN - SCOPUS:85077734925

T3 - Advances in Experimental Medicine and Biology

SP - 1

EP - 29

BT - Advances in Experimental Medicine and Biology

PB - Springer

ER -